Tirzepatide
Metabolic · For research use only
A$99.90 – A$159.90 AUD
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied in metabolic research models for incretin-pathway signalling and glucose-metabolism dynamics. Supplied as a lyophilised, HPLC-verified reference standard for in-vitro laboratory research use only.
Available sizes
- Tirzepatide 10mg — A$99.90 — In stock
- Tirzepatide 20mg — A$159.90 — In stock
View HPLC certificate of analysis (COA)
For laboratory research use only. All products are supplied strictly for in-vitro research and laboratory experimentation. Not for human or veterinary use, not a drug, food, cosmetic, or medical device, and not for diagnostic or therapeutic purposes.